Family caregiver descriptions of stopping chemotherapy and end-of-life transitions
The purpose of this study was to describe family caregivers’ perspectives of the final month of life of patients with advanced cancer, particularly whether and how chemotherapy was discontinued and the effect of clinical decision-making on family caregivers’ perceptions of the patient’s experience of care at the end of life (EOL).
Qualitative descriptive design using semi-structured interviews collected from 92 family caregivers of patients with end-stage cancer enrolled in a randomized clinical trial. We used a phased approach to data analysis including open coding, focused coding, and within and across analyses.
We identified three patterns of transitions characterizing the shift away from active cancer treatment: (1) “We Pretty Much Knew,” characterized by explicit discussions about EOL care, seemingly shared understanding about prognosis and seamless transitions from disease-oriented treatment to comfort-oriented care, (2) “Beating the Odds,” characterized by explicit discussions about disease-directed treatment and EOL care options, but no shared understanding about prognosis and often chaotic transitions to EOL care, and (3) “Left to Die,” characterized by no recall of EOL discussions with transitions to EOL occurring in crisis.
As communication and palliative care interventions continue to develop to improve care for patients with advanced cancer, it is imperative that we take into account the different patterns of transition and their unique patient and caregiver needs near the end of life. Our findings reveal considerable, and potentially unwarranted, variation in transitions from active treatment to death.
KeywordsCancer Caregiver Communication Decision-making End of life Palliative care Prognosis
This study was funded by grants received from the National Institutes of Health, National Cancer Institute: R01CA1404191 and R01CA168387.
- 3.Clayton JM et al (2007) Clinical practice guidelines for communicating prognosis and end-of-life issues with adults in the advanced stages of a life-limiting illness, and their caregivers. Med J Aust 34:81–93Google Scholar
- 4.Wright AA, Zhang B, Ray A, Mack JW, Trice E, Balboni T, Mitchell SL, Jackson VA, Block SD, Maciejewski PK, Prigerson HG (2008) Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. JAMA 300(14):1665–1673CrossRefGoogle Scholar
- 15.Epstein RM et al (2016) Effect of a patient-centered communication intervention on oncologist-patient communication, quality of life, and health care utilization in advanced Cancer: the VOICE randomized clinical trial. JAMA Oncol 3:92–100Google Scholar
- 16.Hoerger M, Epstein RM, Winters PC, Fiscella K, Duberstein PR, Gramling R, Butow PN, Mohile SG, Kaesberg PR, Tang W, Plumb S, Walczak A, Back AL, Tancredi D, Venuti A, Cipri C, Escalera G, Ferro C, Gaudion D, Hoh B, Leatherwood B, Lewis L, Robinson M, Sullivan P, Kravitz RL (2013) Values and options in cancer care (VOICE): study design and rationale for a patient-centered communication and decision-making intervention for physicians, patients with advanced cancer, and their caregivers. BMC Cancer 13(1):188CrossRefGoogle Scholar
- 17.Miles, M.B., A.M. Huberman, and J. Saldaña, Qualitative data analysis : a methods sourcebook. 3rd ed. 2014, Thousand Oaks, Califorinia: SAGE Publications, Inc. xxiii, 381 pagesGoogle Scholar
- 18.Muhr T (2013) ATLAS/ti 7.0 use’s manual and reference. Scientific Software Development GmbH, BerlinGoogle Scholar
- 19.Saldaña J (2013) The coding manual for qualitative researchers, 2nd edn. SAGE Publications, Los AngelesGoogle Scholar
- 20.Maxwell JA (2012) Qualitative research design: an interactive approach, vol Vol. 41. Sage, Thousand OaksGoogle Scholar
- 22.Parker S, Clayton JM, Hancock K, Walder S, Butow P, Carrick S, Currow D, Ghersi D, Glare P, Hagerty R, Tattersall M (2006) Communicating prognosis and issues surrounding end of life (EOL) in adults in the advanced stages of a life-limiting illness: a systematic review. NHMRC Clinical Trials Centre and the University of Sydney, CamperdownGoogle Scholar